Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
Karmela Kim ChanCynthia MagroAlexander N ShoushtariCharles M RudinVeronica M RotembergAnthony RossiCecilia LezcanoJohn A CarrinoDavid FernandezMichael A PostowArlyn ApolloMario E LacoutureAnne R BassPublished in: The oncologist (2019)
It is important for clinicians to recognize that eosinophilic fasciitis is a potential immune-related adverse event (irAE) as a consequence of immune checkpoint inhibitor therapy. The presentation is quite stereotypical; the diagnosis can be made by imaging in the absence of a full-thickness skin biopsy. Early intervention is important to limit morbidity. This irAE may be a good prognostic sign among patients with melanoma.